Clinical Case: Successful Use of Repeated Superselective Arterial Embolization in Metastatic Prostate Cancer Complicated by Bleeding

С. В. Головко, В. Р. Балабаник, А. А. Кобірніченко, І. Л. Троіцький, В. В. Бондарчук


Persistent hematuria, the source of which is a neoplasm of the prostate gland, is a potentially life threatening condition that exacerbates major therapeutic problems. The most common causes of severe hematuria are prostate cancer. Most often, severe recurrent prostatic bleeding occurs with untreated lesions and especially with hormone-refractory form of cancer. In many patients, bleeding cannot be completely controlled by conservative measures, such as routine hemostatic drugs, topical cold, urethral catheter drainage with permanent irrigation with sterile solutions, silver nitrate instillation, or endoscopic diathermy. Currently, the «gold standard» for the treatment of localized prostate cancer is radical prostatectomy. However, radical surgery is not always possible, despite the high efficiency, due to various circumstances, namely: age and due to this factor comorbidities that increase the risk of anesthesia. In this group of patients, it is advisable to use pelvic angiography with embolization, which proved to be a safe and effective method of controlling prostate bleeding. However, the analysis of the results of this technique is based on clinical cases and small, with a limited number of patients, studies. Despite this, selective arterial embolization has become the method of choice when conservative treatments are ineffective.


prostate cancer; hematuria; selective arterial embolization


Delgal A., Cercueil J.P., Koutlidis N., et al. Outcome of transcatheter arterial embolization for bladder and prostate hemorrhage. The Journal of Urology. – 2010 – Vol. 183, p. 1947–1953.

Choong S., Walkden M. and Kirby R. The management of intractable haematuria. BJU Int 2000 – 86 – p. 951.

Nabi G., Sheikh N., Greene D. et al. Therapeutic transcatheter arterial embolization in the management of intractable haemorrhage from pelvic urological malignancies: preliminary experience and long-term follow-up. BJU Int 2003. – 92. – p. 245.

Rastinehad A.R., Caplin D.M., Ost M.C, et al. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology. – 2008 – 71. P. 181.

Carnevale F.C., Motta Leal Filho J.M., Antunes A.A. et al. Quality of life and symptoms relief support prostatic artery embolization for patients with acute urinary retention due to bening prostatic hyperplasia. J Vask Interv Radіol 2012;24(4):535–42.

Pisсo J. M., Pinherio L.C., Bilhim T. et al. Prostatic arterial embolization to teat benign prostatic hyperplasia to treat benign prostatic hyperplasia. J Vask Interv Radiol 2011;22(1):11–9.

Bilhim T., Pisco J.M., Rio Tinto H. et al. Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization. J Vasc Interv Radiol. 2012;23(11):1403–1415.

Chen J.W., Shin J.H., Tsao T.F. et al. Prostatic arterial embolization for control of hematuria in patients with advanced prostate cancer. J Vasc Interv Radiol. 2017;28(02):295–301.

Kim D.H., Lee J.H., Ki Y.K. et al. Shortcourse palliative radiotherapy for uterine cervical cancer. Radiat Oncol J. 2013;31(04):216–221.

Nerli R., Kadeli V., Mulimani N., Ghagane S. Endovascular management in a case of recurrent bleed following transurethral resection of the prostate. Arab. J. Interv. Radiol. 2018;2(1):33.

Cameron M.G., Kersten C., Guren M.G., Fosså S.D., Vistad I. Palliative pelvic radiotherapy of symptomatic incurable prostate cancer – a systematic review. Radiother. Oncol. 2014;110(1): 55–60.

Pereira K., Halpern J.A., McClure T.D. et al. Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. BJU Int. 2016;118(03):359–365.

Copyright (c) 2020 С. В. Головко, В. Р. Балабаник, А. А. Кобірніченко, І. Л. Троіцький, В. В. Бондарчук

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN 2412-5547 (Online), ISSN 2307-5090 (Print)